ADME Toxicology Testing Market
完整報告名稱與涵蓋範圍
ADME Toxicology Testing Market, Share & Trends Analysis Report, By Type of Services (Absorption, Distribution, Metabolism, Excretion), Type of Assays (Batch / Fed-Batch, Continuous), Type of Molecule (Biologics, Small Molecules), End User, Therapeutic Areas, By Region, and Segment Forecasts, 2024-2031
報告摘要
With a 2023 valuation of USD 3.82 Bn, the global ADME Toxicology Testing Market is anticipated to advance to USD 7.12 Bn by 2031, demonstrating a CAGR of 8.3% during the 2024–2031 forecast window.
The ADME Toxicology Testing sector involves the studies designed to investigate how a chemical, such as a drug compound, is processed by a living organism. This domain has witnessed considerable transformation owing to technological breakthroughs and shifting healthcare dynamics.
Growth is supported by a convergence of factors: rising awareness among end users, continuous product innovation, and the expanding emphasis on efficiency and sustainability within the healthcare sector.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
From a regional perspective, mature markets in North America and Europe continue to hold considerable shares, while the Asia-Pacific region is gaining momentum through accelerated economic development and expanding investment in the sector.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
The research provides an in-depth evaluation of market forces, competitive positioning, segmental dynamics, and regional trends, equipping stakeholders with actionable intelligence for the forecast period.
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
目錄 Table of Contents
Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global ADME Toxicology Testing Market Snapshot
Chapter 4. Global ADME Toxicology Testing Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: Type of Services Estimates & Trend Analysis
5.1. Type of Services & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Services:
5.2.1. Absorption
5.2.2. Distribution
5.2.3. Metabolism
5.2.4. Excretion
Chapter 6. Market Segmentation 2: Type of Assays Estimates & Trend Analysis
6.1. Type of Assays & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Assays:
6.2.1. Batch / Fed-Batch
6.2.2. Continuous
Chapter 7. Market Segmentation 3: Type of Molecules Estimates & Trend Analysis
7.1. Type of Molecules & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Type of Molecules:
7.2.1. Biologics
7.2.2. Small Molecules
Chapter 8. Market Segmentation 4: End Users Estimates & Trend Analysis
8.1. End Users & Market Share, 2019 & 2031
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following End Users:
8.2.1. Pharmaceutical and Biotechnology Companies
8.2.2. Academic / Research Institutes
Chapter 9. Market Segmentation 5: Therapeutic Areas Estimates & Trend Analysis
9.1. Therapeutic Areas & Market Share, 2019 & 2031
Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following Therapeutic Areas:
9.1.1. Blood Disorder
9.1.2. Cardiovascular Disorder
9.1.3. Gastrointestinal and Vascular Disorder
9.1.4. Hormonal Disorder
9.1.5. Infectious Diseases
9.1.6. Immunological Disorders
9.1.7. Mental Disorders
9.1.8. Metabolic Disorders
9.1.9. Neurological Disorders
9.1.10. Oncology Disorders
9.1.11. Respiratory Disorders
Chapter 10. ADME Toxicology Testing Market Segmentation 4: Regional Estimates & Trend Analysis
10.1. North America
10.1.1. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Services, 2024-2031
10.1.2. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Assays, 2024-2031
10.1.3. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Molecules, 2024-2031
10.1.4. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts End Users, 2024-2031
10.1.5. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Therapeutic Areas, 2024-2031
10.1.6. North America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
10.2. Europe
10.2.1. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Services, 2024-2031
10.2.2. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Assays, 2024-2031
10.2.3. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Molecules, 2024-2031
10.2.4. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts End Users, 2024-2031
10.2.5. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Therapeutic Areas, 2024-2031
10.2.6. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts xx6, 2024-2031
10.2.7. Europe ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
10.3. Asia Pacific
10.3.1. Asia Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Services, 2024-2031
10.3.2. Asia Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Assays, 2024-2031
10.3.3. Asia-Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Molecules, 2024-2031
10.3.4. Asia-Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts End Users, 2024-2031
10.3.5. Asia-Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Therapeutic Areas, 2024-2031
10.3.6. Asia Pacific ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
10.4. Latin America
10.4.1. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Services, 2024-2031
10.4.2. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Assays, 2024-2031
10.4.3. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Molecules, 2024-2031
10.4.4. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts End Users, 2024-2031
10.4.5. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Therapeutic Areas, 2024-2031
10.4.6. Latin America ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
10.5. Middle East & Africa
10.5.1. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Services, 2024-2031
10.5.2. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Assays, 2024-2031
10.5.3. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts Type of Molecules, 2024-2031
10.5.4. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts End Users, 2024-2031
10.5.5. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Therapeutic Areas, 2024-2031
10.5.6. Middle East & Africa ADME Toxicology Testing Market Revenue (US$ Million) Estimates and Forecasts by country, 2024-2031
Chapter 11. Competitive Landscape
11.1. Major Mergers and Acquisitions/Strategic Alliances
11.2. Company Profiles
11.2.1. Thermo Fisher Scientific Inc.
11.2.2. Promega Corporation
11.2.3. Agilent Technologies, Inc.
11.2.4. Charles River Laboratories
11.2.5. RTI International
11.2.6. Eurofins Scientific
11.2.7. Evotec
11.2.8. Galapagos
11.2.9. Tecan Group
11.2.10. GVK Biosciences
11.2.11. Pharmaron
11.2.12. Pharmaceutical Product Development (PPD)
11.2.13. Sai Life Sciences
11.2.14. Shanghai Medicilon
11.2.15. Syngene International
11.2.16. WuXi AppTec
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們